You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,187,630


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,187,630
Title:Extended release oral dosage composition
Abstract: A bilayer solid composition comprising (a) an immediate release first layer comprising an anti-allergic effective amount of desloratadine and at least one pharmaceutically acceptable excipient and (b) a sustained release second layer comprising an effective amount of a nasal decongestant, e.g. pseudoephedrine sulfate and a pharmaceutically acceptable sustained release agent wherein the composition contains less than about 2% of desloratadine decomposition products is disclosed. A solid composition comprising an anti-allergic effective amount of desloratadine and at least one, and preferably two pharmaceutically acceptable antioxidants is also disclosed.
Inventor(s): Cho; Wing-Kee Philip (Princeton, NJ)
Assignee: Schering-Plough Corporation (Kenilworth, NJ)
Application Number:12/573,022
Patent Claim Types:
see list of patent claims
Composition; Formulation; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,187,630: A Detailed Analysis

Introduction

Patent 8,187,630, like any other patent, is defined by its claims, which are the legal boundaries of the invention's protection. To analyze this patent, it is crucial to delve into the specifics of its claims, the patent landscape, and the broader context of patent law in the United States.

What is Patent 8,187,630?

While the specific details of Patent 8,187,630 are not provided in the sources, we can infer the general approach to analyzing any patent. This patent would typically be categorized under one of the main types of patents: utility, design, or plant patents. The most common type is the utility patent, which covers new and useful processes, machines, manufactures, or compositions of matter, or any new and useful improvement thereof[4].

The Importance of Claims in a Patent Application

The claims in a patent application are essential as they define the scope of the patent's protection. These claims must be clear, concise, and definite to ensure that the invention is properly protected[4].

Analyzing the Claims

To analyze the claims of Patent 8,187,630, one would need to examine each claim individually and understand how they integrate into the overall invention.

Claim Structure

Claims are typically structured in a hierarchical manner, with independent claims standing alone and dependent claims referring back to one or more previous claims. Each claim must be supported by the specification and drawings provided in the patent application[4].

Claim Types

  • Independent Claims: These claims stand alone and do not refer to any other claims. They define the broadest scope of the invention.
  • Dependent Claims: These claims refer back to one or more previous claims and narrow down the scope of the invention.

Claim Language

The language used in the claims is critical. It must be precise and avoid ambiguity to ensure that the scope of protection is clear. For example, claims that integrate judicial exceptions (such as abstract ideas or natural phenomena) into practical applications are more likely to be patent-eligible[1].

Patent Eligibility and Subject Matter

The patent eligibility of claims, especially those involving AI or software, is a complex issue. The 2024 USPTO guidance update provides clarity on this matter by emphasizing the need to integrate judicial exceptions into practical applications. This means that claims must show how the abstract idea is applied in a way that provides concrete benefits or solves specific problems in the relevant field[1].

Practical Applications and Technological Improvements

For a claim to be patent-eligible, it must demonstrate a practical application that results in tangible benefits. For instance, if a claim involves the use of AI in a speech recognition system to enhance the accuracy of voice commands, it must specify how the separated audio components are used in this system to provide a meaningful limit and integrate the judicial exception into a practical application[1].

Patent Landscape and Analytics

Understanding the patent landscape is crucial for managing intellectual property effectively. Patent analytics tools can help identify which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist. This involves categorizing patents by claims and scope concepts, which can be filtered, searched, and analyzed to determine the coverage and value of the patent claims[3].

Claim Coverage Matrix and Scope Concepts

A Claim Coverage Matrix can show which patents and claims are protecting the technology and where gaps or opportunities exist. This matrix categorizes patents not only by claims but also by overarching scope concepts that link claims on similar patents. This approach helps in identifying high-value claims that are crucial to the company, medium-value claims indicating potential future directions, and low-value claims that may not be worth maintaining[3].

Real-World Applications and Benefits

Demonstrating how the claimed method or system is applied in real-world scenarios is vital. For example, if a patent claim involves AI-assisted audio processing, specifying its use in a real-time speech recognition system to enhance voice command accuracy in hands-free environments shows a clear practical application and technological improvement[1].

Industry Expert Insights

Industry experts emphasize the importance of drafting claims that are likely to avoid section 101 rejections, which are common in software-related patent applications. This involves ensuring that the claims integrate judicial exceptions into practical applications and provide meaningful limits that transform the abstract idea into patent-eligible subject matter[1].

Statistics and Trends

Analyzing patent data can provide insights into trends and the effectiveness of patent strategies. The USPTO's Patent Claims Research Dataset, for instance, contains detailed information on claims from U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014. This dataset can help in understanding the scope and trends in patent claims over time[5].

Key Takeaways

  • Claims Define Protection: The claims in a patent application are crucial as they define the scope of the patent's protection.
  • Practical Applications: Claims must integrate judicial exceptions into practical applications to be patent-eligible.
  • Technological Improvements: Claims should demonstrate tangible benefits and technological improvements.
  • Patent Landscape: Understanding the patent landscape through analytics tools is essential for managing intellectual property.
  • Real-World Applications: Demonstrating real-world applications of the claimed method or system is vital.

FAQs

Q: What is the primary purpose of claims in a patent application? A: The primary purpose of claims in a patent application is to define the scope of the patent's protection.

Q: How does the 2024 USPTO guidance update impact AI-related patent claims? A: The update clarifies that AI-assisted inventions are evaluated on equal footing with other technologies, focusing on whether the claimed invention integrates judicial exceptions into practical applications.

Q: What is a Claim Coverage Matrix, and how is it used? A: A Claim Coverage Matrix is a tool used to categorize patents by claims and scope concepts, helping to identify gaps or opportunities in patent coverage and determine the value of patent claims.

Q: Why is it important to specify real-world applications in patent claims? A: Specifying real-world applications helps to demonstrate how the abstract idea is transformed into a practical application, providing tangible benefits and technological improvements.

Q: What resources are available for analyzing patent claims and trends? A: Resources such as the USPTO's Patent Claims Research Dataset and patent analytics tools can provide detailed information and insights into patent claims and trends.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. U.S. Patent and Trademark Office (USPTO) | USAGov
  3. Patent Analytics | Intellectual Property Law - Schwegman
  4. Patents | The Maryland People's Law Library
  5. Patent Claims Research Dataset - USPTO

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,187,630

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,187,630

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1110543 ⤷  Subscribe 91403 Luxembourg ⤷  Subscribe
European Patent Office 1110543 ⤷  Subscribe CA 2008 00010 Denmark ⤷  Subscribe
European Patent Office 1110543 ⤷  Subscribe 300328 Netherlands ⤷  Subscribe
European Patent Office 1110543 ⤷  Subscribe SPC063/2007 Ireland ⤷  Subscribe
European Patent Office 1110543 ⤷  Subscribe 08C0004 France ⤷  Subscribe
European Patent Office 1110543 ⤷  Subscribe SPC/GB08/005 United Kingdom ⤷  Subscribe
European Patent Office 1110543 ⤷  Subscribe 318 Finland ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.